Latest Articles

Publication Date
Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) - BioSpace

Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) BioSpace

Published: Nov. 14, 2025, 11:59 a.m.
Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) - Morningstar

Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) Morningstar

Published: Nov. 13, 2025, 3:15 p.m.
If you’re considering surgery for endometriosis, it’s important to know: we’re not yet at a place where medication alone can solve it. But there is hope. Just as medical advancements have transformed other conditions, we believe a breakthrough is coming. Until - facebook.com

If you’re considering surgery for endometriosis, it’s important to know: we’re not yet at a place where medication alone can solve it. But there is hope. Just as medical advancements …

Published: Nov. 12, 2025, 3:22 p.m.
Evaluation of the long-term efficacy and safety of dydrogesterone in the treatment of endometriosis/dysmenorrhea - BMC Women's Health

Evaluation of the long-term efficacy and safety of dydrogesterone in the treatment of endometriosis/dysmenorrhea BMC Women's Health

Published: Nov. 12, 2025, 3:21 p.m.
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204 - The Manila Times

Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204 The Manila Times

Published: Nov. 12, 2025, 1:33 p.m.
Binnopharm Group expands portfolio of women’s health products - Новости GxP

Binnopharm Group expands portfolio of women’s health products Новости GxP

Published: Nov. 12, 2025, 7:29 a.m.
"Black box" warning from menopause hormone therapy scrapped by FDA - Axios

"Black box" warning from menopause hormone therapy scrapped by FDA Axios

Published: Nov. 11, 2025, 4:54 p.m.
Cutting-Edge Kaiser Permanente Research Is Giving Patients Hope - Kaiser Permanente

Cutting-Edge Kaiser Permanente Research Is Giving Patients Hope Kaiser Permanente

Published: Nov. 10, 2025, 4:33 p.m.
Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor sperm use, or ovulation conditions that respo - facebook.com

Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor …

Published: Nov. 10, 2025, 3:02 p.m.
Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor sperm use, or ovulation conditions that respo - Facebook

Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor …

Published: Nov. 10, 2025, 3:02 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!